1/ 🧵 A CHD manuscript (Feb 2026) argues aluminum vaccine adjuvants cause ASD and claims it “meets all 9 Bradford Hill criteria.” It’s a narrative synthesis, not a randomized trial or new cohort study. (PDF p1–2)
2/ Their headline statistic: ASD prevalence rose “80-fold” and “correlates” with vaccine schedule expansion (r=0.91). That’s a time-trend correlation—useful for hypotheses, weak for causation. (PDF p1)
3/ Why weak? Many things changed over decades (diagnostic criteria, awareness, services). Time-series correlations can be high even when there’s no causal link.
GLP-1 is often framed as a drug target—but it’s first a physiologic gut hormone, released in short pulses when nutrients reach distal L-cells. This thread explains how modern diets silence that system—and how endogenous GLP-1 signaling can be restored. 🧵👇
1/ GLP-1 isn’t just a drug target. It’s a native gut hormone designed to be released in short pulses when nutrients reach distal intestinal L-cells. Modern ultra-processed diets short-circuit this system.
📚 Incretin effect (Nauck et al.)
2/ Key insight: L-cells live mainly in the distal ileum & colon. Rapidly absorbed foods never reach them → calories consumed without satiety signaling. The body interprets this as ongoing energy scarcity.
1/ GLP-1 receptor agonists work—but they bypass normal physiology. This thread reviews how endogenous GLP-1 signaling is suppressed by modern diets, and how gut-centric interventions can restore physiologic, pulsatile incretin release. 🧵👇
2/ The incretin effect shows that oral glucose triggers far greater insulin and satiety responses than IV glucose. This gut-dependent amplification is mediated primarily by GLP-1 and GIP—not by glucose alone.
3/ Enteroendocrine L-cells are enriched in the distal ileum and colon. Rapidly absorbed, ultra-processed foods are cleared proximally—delivering calories without activating distal incretin signaling.
1/ Chair: [gavel tap] “Good morning. I’m calling the first meeting of the Autism Advisory Board to order. As this is our inaugural session, there are no prior minutes to approve. Welcome, everyone.”
2/ Scene: A long federal board table. On the wall: an oversized portrait of Donald Trump, gazing sternly. Beside it, a slightly smaller photo of Robert F. Kennedy Jr..
A glass pitcher of raw milk. Shot glasses at every seat.
3/ Chair: “Before we begin—has everyone read the memo that was circulated ahead of time? The one labeled ‘Marching Orders’?”
Awkward nodding. One member checks the footer for a watermark.
What we know about the newly appointed members — their backgrounds, public positions, and why several selections raise concern from a scientific and public-health consensus perspective.
Thread below. 👇
1/ Sylvia Fogel, MD — psychiatrist working in integrative, PANS-focused care.
⚠️ Caution: immune-driven autism frameworks (PANS/PANDAS) remain controversial and unproven within mainstream autism science.
2/ Daniel Rossignol, MD — clinician associated with experimental biomedical autism interventions.
⚠️ Caution: many promoted treatments lack replication, RCTs, or consensus endorsement.
1/ 🧵Tuskegee is often treated as a closed chapter in medical history.
But as discussed on Beyond the Noise, its real lesson wasn’t about the past — it was about what happens when medicine decides some lives are acceptable collateral damage.
2/ From 1932–1972, Black men with syphilis were deliberately observed but not treated — even after penicillin existed.
Families were harmed. Children were infected.
That was the Tuskegee Study.
3/ Guinea-Bissau today is a high-risk setting for hepatitis B.
Prevalence is extremely high, infections often occur at birth, and mothers are not routinely screened — facts emphasized in the discussion.